Manuel Llobet

FDA Clears Path for Human Clinical Trials of Peanut Allergy Vaccine

Dave Bloom - 2022/01/27

"Virus Like Particle" based vaccine promises short-course treatment providing long-term protection.

Peanut Allergy Vaccine Takes Another Step with Biomarker Study

Dave Bloom - 2021/03/03

Study will help establish the starting dose of its vaccine candidate for a subsequent in-human phase I study.

Allergy Therapeutics Publishes Encouraging New Data for Peanut Allergy Vaccine Candidate

News Wire ~ 3rd Party Press Release - 2020/01/29

"This study indicates a paradigm shift by addressing peanut allergy via a vaccination concept instead of classic desensitisation..."

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: Manuel Llobet

FDA Clears Path for Human Clinical Trials of Peanut Allergy Vaccine

Peanut Allergy Vaccine Takes Another Step with Biomarker Study

Allergy Therapeutics Publishes Encouraging New Data for Peanut Allergy Vaccine Candidate